New lung cancer biomarker Protein PD-1 for predicting survival

The biomarker PD-1, a protein, could potentially be used to predict survival or disease-free survival of lung cancer patients who have had the tumor surgically removed. This is substantiated by the results of a study conducted under the direction of the Comprehensive Cancer Center (CCC) of MedUni Vienna and Vienna General Hospital, together with MedUni… Continue reading New lung cancer biomarker Protein PD-1 for predicting survival

New biomarker based on expression of SHOX2 gene for predicting survival in Gliomas

Researchers at UT Southwestern Medical Center have found a new biomarker for glioma, a common type of brain cancer, that can help doctors determine how aggressive a cancer is and that could eventually help determine the best course of treatment.┬áThe findings are published in EBiomedicine. Researchers from the Harold C. Simmons Comprehensive Cancer Center found… Continue reading New biomarker based on expression of SHOX2 gene for predicting survival in Gliomas

Protein CPEB4 plays crucial role in melanoma

Spanish National Cancer Research Centre (CNIO) Melanoma Group researchers work tirelessly to identify biomarkers of tumor progression and to validate novel therapeutic targets in melanoma. In particular, their research focuses on discovering features that define the “fingerprint” of this tumor, features that distinguish it from other cancer types. The latest study in this area, published… Continue reading Protein CPEB4 plays crucial role in melanoma

Over expression of protein BRD4 associated with breast cancer metastasis

Researchers have identified a new pathway and with it a protein, BRD4, necessary for breast cancer cells to spread. The findings, which appear in the journal Cancer Research, may provide a new target to suppress breast cancer metastasis. Triple-negative breast cancer is considered the worst subgroup of breast cancer. It is highly aggressive and responds… Continue reading Over expression of protein BRD4 associated with breast cancer metastasis

Vitamin D and Breast Cancer survival

Women with higher vitamin D levels in their blood following a breast cancer diagnosis had significantly better long-term outcomes, according to new research from Kaiser Permanente and Roswell Park Cancer Institute. The study was published in JAMA Oncology. “We found that women with the highest levels of vitamin D levels had about a 30 percent… Continue reading Vitamin D and Breast Cancer survival